Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Gene Biotherapeutics, Inc. | crxm-10k_20161231.htm |
| EX-32 - EX-32 - Gene Biotherapeutics, Inc. | crxm-ex32_10.htm |
| EX-31.1 - EX-31.1 - Gene Biotherapeutics, Inc. | crxm-ex311_12.htm |
| EX-23.1 - EX-23.1 - Gene Biotherapeutics, Inc. | crxm-ex231_13.htm |
Exhibit 21.1
Subsidiaries of
Taxus Cardium Pharmaceuticals Group Inc., a Delaware corporation
|
Name of Subsidiary |
|
State or other Jurisdiction of Incorporation or Organization |
|
Angionetics Inc. (85% controlling interest) |
|
Delaware, USA |
|
Post-Hypothermia Corporation |
|
Delaware, USA |
|
Activation Therapeutics, Inc. |
|
Delaware, USA |
|
Life Again Insurance Solutions, Inc. |
|
Delaware, USA |